SEC Form 4/A · accession 0001102624-15-000062
Boston Therapeutics, Inc. · BTHE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
David Platt
Officer — CEO and Chairman · Director · 10% Owner
Period of report
Jan 15, 2015
Accepted (ET)
Jan 20, 2015 · 6:16 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001473579
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 15, 2015 | P | 500 | $0.5999 | A | 7,540,485 | D | |
| Common Stock | Jan 16, 2015 | P | 100 | $0.5999 | A | 7,540,585 | D |
Table II — derivative securities
No Table II lines on this filing.